Algalif Iceland has been awarded as one of the top 10 BioTech Startups in Europe 2021 by the San Francisco-based magazine Startup City. The magazine has 131.000 global subscribers and a strong online presence. Algalif is awarded in appreciation of its “relentless pursuit of excellence and innovation in the BioTech Startups technology.”
Since Algalif started selling Nutramunity Beta Glucan in 2018, total sales have increased 19-fold, from about 200 units sold in the first year to over 4.000 units in 2021 with a substantial increase during the pandemic. Nutramunity Beta Glucan is a high-quality food supplement product made from yeast. It is considered to be one of the most effective immune boosters out there. Nutramunity is a sub-brand of astaxanthin producer Algalíf Iceland. Sales of Nutramunity Beta Glucan have increased significantly in recent years and months. As the chart shows, sales have picked up sharply since the covid pandemic hit the world.
Even though the food supplement and vitamin sector has seen increasing sales during the pandemic, not many ingredients have seen a similar boost. Orri Björnsson, CEO of Algalif, says increased awareness of health has had a positive effect on the sales of Nutramunity Beta Glucan. “We’re seeing more growth in Beta Glucan sales now, than ever before. That, of course, tells us two things. First, Nutramunity Beta Glucan works as intended to strengthen the immune system. Otherwise, people would not continue to buy it. Secondly, there is a great awakening among consumers around the world regarding health and healthy living, as we see in both Beta Glucan and astaxanthin sales.
Algalif Iceland has added two types of astaxanthin beadlets to its product portfolio in partnership with Divi´s Nutraceuticals. These beadlets are made by Divis with sustainable natural astaxanthin from Algalif.
Algalif Iceland has been chosen as one of the top ten companies of the year by the US-based magazine CXO Fortune and received a Certificate of Excellence for outstanding performance and contributions to further enhance technology.
The CXO Fortune magazine was founded in 2015 and has 78.000 premium subscribers and 131.000 network members worldwide. It is a great honor for Algalif to receive this Award of Excellence and to be chosen as one of the best 10 companies worldwide by CXO Fortune.
CXO Foturne profile of Algalif
Algalif has started construction on its 12.500 m² astaxanthin production facilities in Iceland. Today, the honorable Icelandic minister of finance, Mr. Bjarni Benediktsson, and Mr. Kjartan Már Kjartansson, the honorable mayor of Reykjanesbaer, broke ground on the new building.
When it is finished in 2023, it will be the biggest, most sustainable, and most technically advanced astaxanthin production facility in the world. The investment in the expansion project is 30 million US$.
All production will be sustainable and Algalif will stay a zero-fossil fuel company, using only 100% green geothermal energy.
“Everything is going according to plan, and we look forward to being able to serve our customers even better in the coming years as a reliable business partner offering sustainable quality natural astaxanthin products,” says Orri Björnsson, Algalif CEO.
Since its foundation in 2012, Algalif has gained status as an industry leader in the production of high-quality sustainable natural astaxanthin from microalgae. This is due to superb production quality and delivery security, along with extensive industry knowledge of the management team and competitive cost structure.
Global Health and Pharma Biotechnology Awards 2021:
Global Health & Pharma magazine from the UK-based publishing house AI Global Media has awarded Algalif Iceland as the best Natural Astaxanthin Products Supplier of 2021 at the sixth annual Biotechnology Awards.
“We are honored by receiving these esteemed awards,” says Orri Bjornsson, Algalif´s CEO. “But the real honor belongs to our wonderful and dedicated team”.
Algalif is one of the most sustainable companies in its field worldwide. The company recently updated its environmental policy manifesto where the company describes its goals and will to be exemplary and inspire others in environmental matters.
Algalif recently announced plans of 30 million US$ expansion. Production will more than triple when the new facility is operational in 2022. A new state-of-the-art factory will establish Algalif as a worldwide industry leader in astaxanthin production.
Further information about all winners:
www.ghp-news.com/winners/algalif/
www.ghp-news.com/issues/biotechnology-awards-2021
Further information about Global Health and Pharma and AI Global Media:
www.aiglobalmedialtd.com/brands
Further information about Algalif:
Today is the first day of summer according to the old Icelandic calendar. From now on the nights will be short and bright until winter sets in. It is a public holiday in Iceland, so the staff of Algalif might not answer any emails or phone calls until tomorrow.
Happy summer from the Algalif Team.
https://issuu.com/ceomedia/docs/bfm-issue-no.84-i?fr=sOGZjYzE2OTExMzM
About a third of Algalif´s employees are female. They come from all over the world and do all sort of jobs within the company, from production to management and science. We are proud of our women and the company would not be where it is without them. Even though we value them every day, we want to use this opportunity to celebrate them especially on International Women´s Day. Thank you all for your invaluable contribution to the success of Algalif!
#IWD2021
Recent Comments